Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant group » significant amount (Expand Search), significant genes (Expand Search), significant among (Expand Search)
Showing 1 - 20 results of 137 for search '(( significant decrease decrease ) OR ( ((significant gap) OR (significant group)) decrease ))~', query time: 0.61s Refine Results
  1. 1
    AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation.

    AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. by Xiaoqin Li (1399105)

    Published 2025
    Save to List
    Saved in:
  2. 2
    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission.

    NgR1 KO mice exhibited an increase in excitatory synapses and a decrease in inhibitory synapses, indicating an imbalance of synaptic transmission. by Jinwei Zhang (462455)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  11. 11
    BMI groups by SES.

    BMI groups by SES. by Krystal Hunter (6820052)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Outcomes and interventions by group comparison.

    Outcomes and interventions by group comparison. by Shaaista Budhani (21030221)

    Published 2025
    “…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …”
    Save to List
    Saved in:
  13. 13
    Change in Mean Anxiety Scores Over time by group.

    Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

    Published 2025
    “…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …”
    Save to List
    Saved in:
  14. 14
    Number of finishers by age group for women and men with the overall race times for each age group (HH:MM:SS).

    Number of finishers by age group for women and men with the overall race times for each age group (HH:MM:SS). by Beat Knechtle (5504402)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 15
    Men-to-women ratio across age groups.

    Men-to-women ratio across age groups. by Beat Knechtle (5504402)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 16
    Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions.

    Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Health inequalities in the burden of IBD among WCBA.

    Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040.

    Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021.

    The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040.

    Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: